The content on this site is intended for healthcare professionals only
Combination of newer agents in advanced melanoma (4/6)
Recent advances in advanced melanoma: ipilimumab (2/6)
Changing drug discovery: share data
Emergence of ipilimumab and vemurafenib for melanoma
Key CLL research from EHA 2011
Role of vemurafenib in melanoma treatment
The changing landscape of melanoma therapies: indications of better patient outcome
ASCO 2011: Key head and neck cancer research
PTEN expression does not diminish trastuzumab effectiveness
Ipilimumab improves survival in metastatic melanoma
Future for immunotherapies
ASCO 2011 highlights
